Participants who complete the study will have the option to enter the long-term extension Study I6T-MC-AMAZ (AMAZ).
The main purpose of this study is to investigate efficacy, pharmacokinetics and safety of the drug in pediatric participants with moderately to severely active ulcerative colitis (UC).